Cite
HARVARD Citation
Fu, R. et al. (2022). Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis. Bioengineered. 13 (4), pp. 10914-10930. [Online].